Lipoatrophy in a Girl With Type 1 Diabetes: Beneficial Effects of Treatment With a Glucocorticoid Added to an Insulin Analog
Author(s) -
Hester T. Swelheim,
Ciska Westerlaken,
Evelyn van Pinxteren-Nagler,
Gianni Bocca
Publication year - 2012
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc11-2135
Subject(s) - medicine , glucocorticoid , lipoatrophy , diabetes mellitus , insulin , girl , endocrinology , type 2 diabetes , human immunodeficiency virus (hiv) , immunology , antiretroviral therapy , viral load , psychology , developmental psychology
Lipoatrophy has been reported in association with the use of human insulin analogs (1). We report on a girl with severe lipoatrophy who was treated with betamethasone added to the insulin analog, after which the areas of lipoatrophy improved.A 7-year-old girl with type 1 diabetes, treated with insulin-aspart by continuous subcutaneous insulin infusion, developed areas of lipoatrophy at her insulin infusion sites, which initially only involved the buttocks. A few months later, areas of lipoatrophy were also seen on her thighs. The areas of lipoatrophy on her left and right buttocks measured 7 × 7 cm and 7 × 6 cm, respectively. Laboratory investigation excluded the presence of insulin antibodies. A skin biopsy was not performed.Initially, insulin-aspart was substituted with insulin-lispro. Because …
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom